within Pharmacolibrary.Drugs.ATC.B;

model B03AA02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.1,
    Cl             = 0.0011666666666666668,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ferrous fumarate is an iron supplement used for the prevention and treatment of iron deficiency anemia. It is commonly administered orally and is approved for use in many countries for this indication.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adult individuals after oral administration. Few published data directly report 'classical' compartmental PK parameters for non-intravenous oral iron such as ferrous fumarate. The following values are approximate estimates based on general absorption and elimination patterns of oral iron formulations.</p><h4>References</h4><ol><li><p>Liu, TC, et al., &amp; Chen, TP (2004). Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: a Taiwanese study. <i>International journal of hematology</i> 80(5) 416–420. DOI:<a href=&quot;https://doi.org/10.1532/ijh97.a10409&quot;>10.1532/ijh97.a10409</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/15646652/&quot;>https://pubmed.ncbi.nlm.nih.gov/15646652</a></p></li><li><p>Ryszka, F, et al., &amp; Doliński, W (1998). Pharmacokinetics of ferrous fumarate in rats. <i>Bollettino chimico farmaceutico</i> 137(5) 178–179. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9689905/&quot;>https://pubmed.ncbi.nlm.nih.gov/9689905</a></p></li><li><p>Brouwers, JR, et al., &amp; Proost, JH (1990). Decreased ciprofloxacin absorption with concomitant administration of ferrous fumarate. <i>Pharmaceutisch weekblad. Scientific edition</i> 12(5) 182–183. DOI:<a href=&quot;https://doi.org/10.1007/BF01980042&quot;>10.1007/BF01980042</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2255585/&quot;>https://pubmed.ncbi.nlm.nih.gov/2255585</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end B03AA02;
